{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Fbb73e4e6-feaa-4439-93f8-eba62f6509fc","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Special Edition \u2014 Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/bb73e4e6-feaa-4439-93f8-eba62f6509fc\"></iframe>","title":"Special Edition \u2014 Management of ER-Positive Breast Cancer with Drs Erica Mayer and Ruth O'Regan","description":"\n        <p>Dr Erica Mayer from the Dana-Farber Cancer Institute in Boston, Massachusetts and Dr Ruth O&#39;Regan from the University of Rochester in Rochester, New York discuss new developments in ER-positive breast cancer.</p>\n\n<p>CME information and select publications <a href=\"http://www.researchtopractice.com/OncologyTodayERPositiveBreastCancer23\" rel=\"nofollow\">here</a>.</p>\n      ","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/b779d195-cbed-4bdb-b358-0e383d18c2af/cover.jpg"}